Roche granted breakthrough status for liver cancer combo
Based on data from a Phase Ib study, Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) were given the breakthrough designation as a...
EPO under pressure not to lower quality standards
In a letter send to the outgoing EPO president Benoît Battistelli, four reowned law firms – Grünecker, Hoffmann Eitle, Maiwald und...
Lifecare floats on Oslo stock exchange
Lifecare AS was admitted to start trading outstanding shares on Merkur Market on July 10. The Bergen-based life-science company researches and...
Roche set to extend Hemlibra label
In December 2017, the FDA approved Roche's bispecific antibody for the about 30% of 320,000 hemophilia A patients worldwide who have antibodies...
Go Jelly, go
Jellagen is one of the first commercial manufacturers of next-generation jellyfish collagen for cell culture and medical applications, inlcuding...
Sobi in €387 orphan drug deal with Novimmune
The exclusive licence agreement will give Sobi the rights to emapalumab, an anti-interferon-gamma monoclonal antibody, which currently being reviewed...
Irish Iterum files for IPO on Nasdaq
The Dublin, Ireland-based company with a headcount of 29 was founded in 2015 and booked US$0.5m in revenue for the 12 months ended December 31, 2017....